Trupanion (NASDAQ:TRUP) Posts Earnings Results, Misses Expectations By $0.02 EPS

Trupanion (NASDAQ:TRUP) issued its earnings results on Wednesday. The financial services provider reported $0.04 EPS for the quarter, missing the consensus estimate of $0.06 by ($0.02), Zacks reports. Trupanion had a negative return on equity of 4.36% and a negative net margin of 1.08%.

Trupanion Price Performance

TRUP stock traded down $1.18 during mid-day trading on Wednesday, hitting $47.51. The stock had a trading volume of 667,666 shares, compared to its average volume of 508,901. The firm has a fifty day simple moving average of $48.54 and a 200 day simple moving average of $47.98. Trupanion has a 52 week low of $19.69 and a 52 week high of $57.90. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 0.40. The firm has a market capitalization of $2.01 billion, a P/E ratio of -148.47, a P/E/G ratio of 8.66 and a beta of 1.60.

Wall Street Analyst Weigh In

A number of brokerages recently commented on TRUP. Stifel Nicolaus upped their price target on shares of Trupanion from $42.00 to $44.00 and gave the company a “hold” rating in a research note on Monday, January 6th. Northland Securities upped their target price on Trupanion from $45.00 to $50.00 and gave the company a “market perform” rating in a research report on Thursday, October 31st. Finally, Piper Sandler raised Trupanion from a “neutral” rating to an “overweight” rating and set a $57.00 price target for the company in a report on Thursday, January 23rd. Two investment analysts have rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $45.33.

Insider Activity at Trupanion

In other Trupanion news, CFO Fawwad Qureshi sold 622 shares of the firm’s stock in a transaction on Tuesday, November 26th. The stock was sold at an average price of $52.61, for a total value of $32,723.42. Following the sale, the chief financial officer now owns 9,867 shares of the company’s stock, valued at approximately $519,102.87. This trade represents a 5.93 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, SVP Emily Dreyer sold 900 shares of the business’s stock in a transaction on Monday, November 25th. The stock was sold at an average price of $54.55, for a total value of $49,095.00. Following the transaction, the senior vice president now directly owns 23,808 shares of the company’s stock, valued at $1,298,726.40. This trade represents a 3.64 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 26,597 shares of company stock valued at $1,416,742 over the last three months. 5.50% of the stock is owned by insiders.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.